PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SNY vs. JNJ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


SNYJNJ
YTD Return-1.01%-7.75%
1Y Return-4.27%-9.59%
3Y Return (Ann)1.76%-1.45%
5Y Return (Ann)6.59%3.09%
10Y Return (Ann)2.94%6.63%
Sharpe Ratio-0.17-0.64
Daily Std Dev26.65%15.04%
Max Drawdown-46.65%-50.68%
Current Drawdown-10.82%-18.33%

Fundamentals


SNYJNJ
Market Cap$122.65B$352.17B
EPS$2.30$7.42
PE Ratio21.3619.70
PEG Ratio0.840.89
Revenue (TTM)$46.29B$85.65B
Gross Profit (TTM)$31.70B$63.95B
EBITDA (TTM)$12.20B$30.67B

Correlation

-0.50.00.51.00.4

The correlation between SNY and JNJ is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

SNY vs. JNJ - Performance Comparison

In the year-to-date period, SNY achieves a -1.01% return, which is significantly higher than JNJ's -7.75% return. Over the past 10 years, SNY has underperformed JNJ with an annualized return of 2.94%, while JNJ has yielded a comparatively higher 6.63% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


250.00%300.00%350.00%400.00%450.00%NovemberDecember2024FebruaryMarchApril
251.41%
412.79%
SNY
JNJ

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Sanofi

Johnson & Johnson

Risk-Adjusted Performance

SNY vs. JNJ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SNY
Sharpe ratio
The chart of Sharpe ratio for SNY, currently valued at -0.17, compared to the broader market-2.00-1.000.001.002.003.00-0.17
Sortino ratio
The chart of Sortino ratio for SNY, currently valued at -0.04, compared to the broader market-4.00-2.000.002.004.006.00-0.04
Omega ratio
The chart of Omega ratio for SNY, currently valued at 0.99, compared to the broader market0.501.001.500.99
Calmar ratio
The chart of Calmar ratio for SNY, currently valued at -0.21, compared to the broader market0.002.004.006.00-0.21
Martin ratio
The chart of Martin ratio for SNY, currently valued at -0.47, compared to the broader market-10.000.0010.0020.0030.00-0.47
JNJ
Sharpe ratio
The chart of Sharpe ratio for JNJ, currently valued at -0.64, compared to the broader market-2.00-1.000.001.002.003.00-0.64
Sortino ratio
The chart of Sortino ratio for JNJ, currently valued at -0.84, compared to the broader market-4.00-2.000.002.004.006.00-0.84
Omega ratio
The chart of Omega ratio for JNJ, currently valued at 0.90, compared to the broader market0.501.001.500.90
Calmar ratio
The chart of Calmar ratio for JNJ, currently valued at -0.52, compared to the broader market0.002.004.006.00-0.52
Martin ratio
The chart of Martin ratio for JNJ, currently valued at -1.16, compared to the broader market-10.000.0010.0020.0030.00-1.16

SNY vs. JNJ - Sharpe Ratio Comparison

The current SNY Sharpe Ratio is -0.17, which is higher than the JNJ Sharpe Ratio of -0.64. The chart below compares the 12-month rolling Sharpe Ratio of SNY and JNJ.


Rolling 12-month Sharpe Ratio-0.500.000.50NovemberDecember2024FebruaryMarchApril
-0.17
-0.64
SNY
JNJ

Dividends

SNY vs. JNJ - Dividend Comparison

SNY's dividend yield for the trailing twelve months is around 3.86%, more than JNJ's 3.29% yield.


TTM20232022202120202019201820172016201520142013
SNY
Sanofi
3.86%3.82%4.22%3.80%3.61%3.46%4.29%3.67%4.03%3.77%4.19%3.47%
JNJ
Johnson & Johnson
3.29%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%2.64%2.83%

Drawdowns

SNY vs. JNJ - Drawdown Comparison

The maximum SNY drawdown since its inception was -46.65%, smaller than the maximum JNJ drawdown of -50.68%. Use the drawdown chart below to compare losses from any high point for SNY and JNJ. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%NovemberDecember2024FebruaryMarchApril
-10.82%
-18.33%
SNY
JNJ

Volatility

SNY vs. JNJ - Volatility Comparison

Sanofi (SNY) has a higher volatility of 7.88% compared to Johnson & Johnson (JNJ) at 4.50%. This indicates that SNY's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%NovemberDecember2024FebruaryMarchApril
7.88%
4.50%
SNY
JNJ

Financials

SNY vs. JNJ - Financials Comparison

This section allows you to compare key financial metrics between Sanofi and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items